COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT

To provide a method for percutaneous absorption of a hydrophilic drug by using a low molecular gelling agent in order to improve not only a use feeling but also percutaneous absorption properties.SOLUTION: A method for percutaneous absorption of a hydrophilic drug is characterized by using a lipid p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOTO MASAHIRO, IMOTO TAKAYUKI, IWAMA TAKEHISA, MIYAJI NOBUHIDE
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GOTO MASAHIRO
IMOTO TAKAYUKI
IWAMA TAKEHISA
MIYAJI NOBUHIDE
description To provide a method for percutaneous absorption of a hydrophilic drug by using a low molecular gelling agent in order to improve not only a use feeling but also percutaneous absorption properties.SOLUTION: A method for percutaneous absorption of a hydrophilic drug is characterized by using a lipid peptide compound consisting of at least one of a compound represented by the formula (1) and an analogous compound thereof or a pharmaceutically usable salt thereof (in the formula, R1 represents an aliphatic group having 9 to 23 carbon atoms, R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, R3 represents a -(CH2)n-X group, n represents a numeral number of 1 to 4, and X represents an amino group, a guanidino group, a -CONH2 group, or a fused heterocycle comprising a 5- or 6-membered ring or 5- and 6-membered rings which may have 1 to 3 nitrogen atoms).SELECTED DRAWING: None 【課題】低分子ゲル化剤を用い、使用感のみならず経皮吸収性の向上を図った親水性薬物を経皮吸収させる方法を提供すること。【解決手段】下記式(1)で表される化合物並びにその類似化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物を用いることを特徴とする、親水性薬物を経皮吸収させる方法。【化1】(式中、R1は炭素原子数9乃至23の脂肪族基を表し、R2は水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基を表し、R3は−(CH2)n−X基を表し、nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、−CONH2基、又は窒素原子を1乃至3個有し得る5員環若しくは6員環又は5員環と6員環から構成される縮合複素環を表す。)【選択図】なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2021100981A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2021100981A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2021100981A3</originalsourceid><addsrcrecordid>eNrjZLBz9vcN8A_2DPH091Nw8w9SCAjy9_UP8fRzVwhwDXIODXH0c_UPDVZwdAr2DwoAq_J3U_AI9XV1BkqF8DCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeK8AIwMjQ0MDA0sLQ0djohQBAPpNKyA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT</title><source>esp@cenet</source><creator>GOTO MASAHIRO ; IMOTO TAKAYUKI ; IWAMA TAKEHISA ; MIYAJI NOBUHIDE</creator><creatorcontrib>GOTO MASAHIRO ; IMOTO TAKAYUKI ; IWAMA TAKEHISA ; MIYAJI NOBUHIDE</creatorcontrib><description>To provide a method for percutaneous absorption of a hydrophilic drug by using a low molecular gelling agent in order to improve not only a use feeling but also percutaneous absorption properties.SOLUTION: A method for percutaneous absorption of a hydrophilic drug is characterized by using a lipid peptide compound consisting of at least one of a compound represented by the formula (1) and an analogous compound thereof or a pharmaceutically usable salt thereof (in the formula, R1 represents an aliphatic group having 9 to 23 carbon atoms, R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, R3 represents a -(CH2)n-X group, n represents a numeral number of 1 to 4, and X represents an amino group, a guanidino group, a -CONH2 group, or a fused heterocycle comprising a 5- or 6-membered ring or 5- and 6-membered rings which may have 1 to 3 nitrogen atoms).SELECTED DRAWING: None 【課題】低分子ゲル化剤を用い、使用感のみならず経皮吸収性の向上を図った親水性薬物を経皮吸収させる方法を提供すること。【解決手段】下記式(1)で表される化合物並びにその類似化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物を用いることを特徴とする、親水性薬物を経皮吸収させる方法。【化1】(式中、R1は炭素原子数9乃至23の脂肪族基を表し、R2は水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基を表し、R3は−(CH2)n−X基を表し、nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、−CONH2基、又は窒素原子を1乃至3個有し得る5員環若しくは6員環又は5員環と6員環から構成される縮合複素環を表す。)【選択図】なし</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210708&amp;DB=EPODOC&amp;CC=JP&amp;NR=2021100981A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210708&amp;DB=EPODOC&amp;CC=JP&amp;NR=2021100981A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOTO MASAHIRO</creatorcontrib><creatorcontrib>IMOTO TAKAYUKI</creatorcontrib><creatorcontrib>IWAMA TAKEHISA</creatorcontrib><creatorcontrib>MIYAJI NOBUHIDE</creatorcontrib><title>COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT</title><description>To provide a method for percutaneous absorption of a hydrophilic drug by using a low molecular gelling agent in order to improve not only a use feeling but also percutaneous absorption properties.SOLUTION: A method for percutaneous absorption of a hydrophilic drug is characterized by using a lipid peptide compound consisting of at least one of a compound represented by the formula (1) and an analogous compound thereof or a pharmaceutically usable salt thereof (in the formula, R1 represents an aliphatic group having 9 to 23 carbon atoms, R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, R3 represents a -(CH2)n-X group, n represents a numeral number of 1 to 4, and X represents an amino group, a guanidino group, a -CONH2 group, or a fused heterocycle comprising a 5- or 6-membered ring or 5- and 6-membered rings which may have 1 to 3 nitrogen atoms).SELECTED DRAWING: None 【課題】低分子ゲル化剤を用い、使用感のみならず経皮吸収性の向上を図った親水性薬物を経皮吸収させる方法を提供すること。【解決手段】下記式(1)で表される化合物並びにその類似化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物を用いることを特徴とする、親水性薬物を経皮吸収させる方法。【化1】(式中、R1は炭素原子数9乃至23の脂肪族基を表し、R2は水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基を表し、R3は−(CH2)n−X基を表し、nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、−CONH2基、又は窒素原子を1乃至3個有し得る5員環若しくは6員環又は5員環と6員環から構成される縮合複素環を表す。)【選択図】なし</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBz9vcN8A_2DPH091Nw8w9SCAjy9_UP8fRzVwhwDXIODXH0c_UPDVZwdAr2DwoAq_J3U_AI9XV1BkqF8DCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeK8AIwMjQ0MDA0sLQ0djohQBAPpNKyA</recordid><startdate>20210708</startdate><enddate>20210708</enddate><creator>GOTO MASAHIRO</creator><creator>IMOTO TAKAYUKI</creator><creator>IWAMA TAKEHISA</creator><creator>MIYAJI NOBUHIDE</creator><scope>EVB</scope></search><sort><creationdate>20210708</creationdate><title>COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT</title><author>GOTO MASAHIRO ; IMOTO TAKAYUKI ; IWAMA TAKEHISA ; MIYAJI NOBUHIDE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2021100981A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GOTO MASAHIRO</creatorcontrib><creatorcontrib>IMOTO TAKAYUKI</creatorcontrib><creatorcontrib>IWAMA TAKEHISA</creatorcontrib><creatorcontrib>MIYAJI NOBUHIDE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOTO MASAHIRO</au><au>IMOTO TAKAYUKI</au><au>IWAMA TAKEHISA</au><au>MIYAJI NOBUHIDE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT</title><date>2021-07-08</date><risdate>2021</risdate><abstract>To provide a method for percutaneous absorption of a hydrophilic drug by using a low molecular gelling agent in order to improve not only a use feeling but also percutaneous absorption properties.SOLUTION: A method for percutaneous absorption of a hydrophilic drug is characterized by using a lipid peptide compound consisting of at least one of a compound represented by the formula (1) and an analogous compound thereof or a pharmaceutically usable salt thereof (in the formula, R1 represents an aliphatic group having 9 to 23 carbon atoms, R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, R3 represents a -(CH2)n-X group, n represents a numeral number of 1 to 4, and X represents an amino group, a guanidino group, a -CONH2 group, or a fused heterocycle comprising a 5- or 6-membered ring or 5- and 6-membered rings which may have 1 to 3 nitrogen atoms).SELECTED DRAWING: None 【課題】低分子ゲル化剤を用い、使用感のみならず経皮吸収性の向上を図った親水性薬物を経皮吸収させる方法を提供すること。【解決手段】下記式(1)で表される化合物並びにその類似化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物を用いることを特徴とする、親水性薬物を経皮吸収させる方法。【化1】(式中、R1は炭素原子数9乃至23の脂肪族基を表し、R2は水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基を表し、R3は−(CH2)n−X基を表し、nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、−CONH2基、又は窒素原子を1乃至3個有し得る5員環若しくは6員環又は5員環と6員環から構成される縮合複素環を表す。)【選択図】なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2021100981A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS
title COMPOSITION FOR PROMOTING PERCUTANEOUS ABSORPTION OF HUMECTANT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A18%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOTO%20MASAHIRO&rft.date=2021-07-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2021100981A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true